Natural Products for Dyslipidemias
Please read through the following information and click continue.
ACPE Universal Program Number:
207-000-09-003-H01-P
Release Date: March 1, 2009
Expiration Date: March 1, 2012
Statement
of Need
More
than 100 million Americans age 20 and older have high cholesterol. The
Third Report of the National Cholesterol Education Program (NCEP III)
Expert Panel established guidelines for identifying, diagnosing and
treating these patients. Patients are using alternative treatments for
dyslipidemia more than ever. Pharmacists armed with appropriate
knowledge on these natural products can educate patients to make
informed decisions about their care. Pharmacists should be familiar
with efficacy, safety, drug interactions, monitoring and dosing
strategies for commonly used complementary therapies.
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- Evaluate fasting lipid panels and establish goals for therapy based on patient specific information.
- Identify natural products used for dyslipidemias.
- Outline role in therapy, adverse effects, and drug interactions for each product.
- Select/recommend safe and effective natural products for patients with dyslipidemias.
- Educate patients on appropriate use of natural products for dyslipidemias.
Target
Audience
The
target audience for this activity is pharmacists.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This program will provide 2.0 contact hours (.20 CEUs) of continuing
pharmacy education credit under the number 207-000-09-003-H01-P.
Faculty
Jennifer
M. Malinowski, PharmD,
is an assistant professor of pharmacy
practice at Wilkes University School of Pharmacy and a clinical
pharmacist
in Scranton, Pennsylvania.
Disclosure
Declaration
It
is
the policy of the National Community Pharmacists Association (NCPA) to
ensure independence, balance, objectivity, scientific rigor,
and integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
SoftwareRequirements
| PC Internet Explorer 5.5 or greater Firefox Windows 2000 SE or greater *Adobe Acrobat Reader |
MAC |
| *Required to view Printable PDF Version | |